Whole-Inactivated Influenza Virus Is a Potent Adjuvant for Influenza Peptides Containing CD8+ T Cell Epitopes

Soema, P.C.; Rosendahl, Huber S.K.; Willems, G.J.; Jacobi, R.; Hendriks, M.; Soethout, E.; ... ; Amorij, J.-P. (2018)

Article / Letter to editor

• whole-inactivated influenza virus
• adjuvant
• T cell peptide
• CTL
• design of experiments
• formulation
• peptide vaccine

• All authors: Soema, P.C.; Rosendahl, Huber S.K.; Willems, G.J.; Jacobi, R.; Hendriks, M.; Soethout, E.; Jiskoot, W.; Jonge, J. de; Beek, J. van; Kersten, G.F.A.; Amorij, J.-P.
• Date: 2018-03-14
• Journal: Frontiers in Immunology
• Volume: 9
• Pages: 525
• DOI: doi:10.3389/fimmu.2018.00525